Breaking News Instant updates and real-time market news.

DOVA

Dova Pharmaceuticals

$20.14 /

-0.05 (-0.25%)

, BBBY

Bed Bath & Beyond

$9.89 /

+0.09 (+0.92%)

09:10
09/30/19
09/30
09:10
09/30/19
09:10

Fly Intel: Pre-market Movers

HIGHER: Dova Pharmaceuticals (DOVA), up 39% after entering into an agreement and plan of merger with Swedish Orphan Biovitrum, or Sobi. Under the terms of the agreement, an indirect subsidiary of Sobi will commence a tender offer for all outstanding shares of Dova, whereby Dova stockholders will be offered an upfront payment for $27.50 per share in cash, along with one non-tradeable contingent value right that entitles them to an additional $1.50 per share in cash upon regulatory approval of DOPTELET... Bed Bath & Beyond (BBBY), up 7% after Wedbush analyst Seth Basham upgraded the stock to Outperform from Neutral and raised his price target for the shares to $16 from $14. Bed Bath & Beyond has a "good chance of stabilization" in earnings over the next two years as its changes take hold, Basham tells investors... Calithera Biosciences (CALA), up 9% after presenting new data from the investigational oral arginase inhibitor INCB001158 as a monotherapy and in combination with the checkpoint inhibitor pembrolizumab in microsatellite stable colorectal carcinoma patients... Mallinckrodt (MNK), up 5% after executing a definitive settlement agreement and release with Cuyahoga and Summit Counties in Ohio in connection with lawsuits pending in multidistrict opioid litigation in the U.S. District Court for the Northern District of Ohio... Colony Capital (CLNY), up 3% after entering into definitive agreements for Blackstone Real Estate Partners IX to acquire Colony Industrial, the industrial real estate assets and affiliated industrial operating platform of Colony Capital, for an aggregate purchase price of $5.9B. LOWER: Immunomedics (IMMU), down 7.5% after presenting interim data from the 100-patient cohort of cisplatin-eligible patients of the company's TROPHY-U-01 open-label Phase 2 study. In this interim report, sacituzumab govitecan produced an overall response rate of 29% in 35 patients with metastatic urothelial cancer who have relapsed or are refractory to immune checkpoint inhibitors and platinum-based chemotherapy... Teekay LNG (TGP) and Teekay Corp. (TK), down 7% and 5%, respectively, after postponing their group investor day.

DOVA

Dova Pharmaceuticals

$20.14 /

-0.05 (-0.25%)

BBBY

Bed Bath & Beyond

$9.89 /

+0.09 (+0.92%)

CALA

Calithera Biosciences

$3.27 /

-0.01 (-0.30%)

MNK

Mallinckrodt

$2.26 /

-0.02 (-0.88%)

CLNY

Colony Capital

$5.90 /

+0.15 (+2.61%)

IMMU

Immunomedics

$14.33 /

-0.02 (-0.14%)

TGP

Teekay LNG

$15.12 /

-0.34 (-2.20%)

TK

Teekay Corp.

$4.23 /

-0.24 (-5.37%)

  • 30

    Sep

  • 30

    Sep

  • 02

    Oct

  • 02

    Oct

  • 02

    Oct

  • 02

    Oct

DOVA Dova Pharmaceuticals
$20.14 /

-0.05 (-0.25%)

09/19/19 H.C. Wainwright
Dova Pharmaceuticals price target raised to $45 from $39 at H.C. Wainwright
08/29/19
Fly Intel: Top five analyst initiations
08/29/19
Oppenheimer bullish on Dova Pharmaceuticals, initiates with an Outperform
08/28/19 Oppenheimer
Dova Pharmaceuticals initiated with an Outperform at Oppenheimer
BBBY Bed Bath & Beyond
$9.89 /

+0.09 (+0.92%)

09/30/19 Wedbush
Wedbush upgrades Bed Bath & Beyond to Outperform, sees 62% upside potential
09/30/19 Wedbush
Bed Bath & Beyond upgraded to Outperform from Neutral at Wedbush
08/20/19 BofA
Bed Bath & Beyond price target lowered to $20 from $21 at BofA/Merrill
08/09/19 Evercore ISI
Bed Bath & Beyond upgraded to In Line from Underperform at Evercore ISI
CALA Calithera Biosciences
$3.27 /

-0.01 (-0.30%)

05/30/19 Citi
Calithera Biosciences assumed with a Buy at Citi
MNK Mallinckrodt
$2.26 /

-0.02 (-0.88%)

09/10/19 Stifel
Mallinckrodt's sale of BioVectra helps alleviate cash pressure, says Stifel
09/09/19 Stifel
Mallinckrodt price target lowered to $8 from $20 at Stifel
09/05/19
Fly Intel: Top five analyst downgrades
09/05/19
Mallinckrodt cut to Market Perform at BMO Capital on opioid restructuring report
CLNY Colony Capital
$5.90 /

+0.15 (+2.61%)

07/05/19 B. Riley FBR
Northstar Realty Europe sale positive for Colony Capital, says B. Riley FBR
10/05/18
Colony Industrial acquires nine industrial properties in Atlanta
IMMU Immunomedics
$14.33 /

-0.02 (-0.14%)

09/29/19 Piper Sandler
Piper Jaffray says some may be disappointed by Immunomedics TROPHY response rate
09/10/19 Jefferies
Immunomedics competitor shows 'impressive' efficacy, AEs cause concern, says Jefferies
09/10/19 Piper Sandler
Safety signals arise for potential Immunomedics competitor, says Piper Jaffray
08/20/19
Fly Intel: Top five analyst initiations
TGP Teekay LNG
$15.12 /

-0.34 (-2.20%)

01/22/19
Teekay LNG upgraded to Overweight following 45% pullback at Morgan Stanley
01/22/19 Morgan Stanley
Teekay LNG upgraded to Overweight from Equal Weight at Morgan Stanley
11/28/18 Stifel
Teekay LNG upgraded to Buy from Hold at Stifel
11/21/18 Wells Fargo
Teekay LNG price target lowered to $15 from $22 at Wells Fargo
TK Teekay Corp.
$4.23 /

-0.24 (-5.37%)

01/22/19
Teekay Offshore Partners downgraded to Underweight at Morgan Stanley
10/22/18 BofA
Teekay Corp. initiated with a Buy at BofA/Merrill

TODAY'S FREE FLY STORIES

Hot Stocks
AbbVie says Phase 3 trial of venetoclax combo did not meet primary endpoint » 18:57
02/28/20
02/28
18:57
02/28/20
18:57
ABBV

AbbVie

$85.27 /

-0.065 (-0.08%)

AbbVie announced the…

AbbVie announced the VIALE-C trial of venetoclax in combination with low-dose cytarabine versus LDAC in combination with placebo did not meet its primary endpoint of statistically significant improvement of overall survival for patients with acute myeloid leukemia who are ineligible for intensive chemotherapy at the time of the planned analysis.Treatment with the venetoclax combination showed a 25% reduction in the risk of death compared to LDAC with placebo. The venetoclax with LDAC arm also showed a median OS of 7.2 months vs. 4.1 months in the LDAC arm alone. A post-hoc analysis after an additional six months of follow up showed an increase in median OS of 8.4 months in the venetoclax plus LDAC arm and 4.1 months in the placebo plus LDAC arm.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Invitation Homes cancels participation at Citi Global Property CEO Conference » 18:32
02/28/20
02/28
18:32
02/28/20
18:32
INVH

Invitation Homes

$28.65 /

-0.29 (-1.00%)

Invitation Homes…

Invitation Homes announced the cancellation of the company's roundtable discussion and webcast at Citi's 2020 Global Property CEO Conference, previously scheduled to take place on Tuesday, March 3, at 10:20 a.m. Eastern Time. Management no longer plans to attend the conference out of an abundance of caution amidst evolving uncertainty related to COVID-19.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Hudson Pacific cancels presentation at Citi 2020 Global Property CEO Conference » 18:31
02/28/20
02/28
18:31
02/28/20
18:31
HPP

Hudson Pacific

$32.26 /

-1.15 (-3.44%)

Hudson Pacific Properties…

Hudson Pacific Properties announced the cancellation of the company's presentation and webcast at Citi's 2020 Global Property CEO Conference, previously scheduled to take place on Tuesday, March 3, at 11:00 a.m. ET. Management no longer plans to attend the conference in light of a growing list of cancellations.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
CatchMark Timber files $600M mixed securities shelf  18:25
02/28/20
02/28
18:25
02/28/20
18:25
CTT

CatchMark Timber

$9.17 /

-0.48 (-4.97%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Westwater Resources files $50M mixed securities shelf  18:24
02/28/20
02/28
18:24
02/28/20
18:24
WWR

Westwater Resources

$1.77 /

+0.05 (+2.91%)

 
Hot Stocks
Clean Harbors CEO: We have a good year ahead of us » 18:23
02/28/20
02/28
18:23
02/28/20
18:23
CLH

Clean Harbors

$69.16 /

-3.69 (-5.07%)

In an interview on…

In an interview on CNBC's Mad Money, Clean Harbors CEO Alan McKim said, "We had a great fourth quarter and have a good year ahead of us." He noted that the company's environmental business is really strong and expects that trend to continue in 2020. McKim added that customers are buying into the company's sustainability efforts.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Teladoc to host investor day » 17:56
02/28/20
02/28
17:56
02/28/20
17:56
TDOC

Teladoc

$124.79 /

-10.38 (-7.68%)

Investor Day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
General Electric to hold a conference call » 17:52
02/28/20
02/28
17:52
02/28/20
17:52
GE

General Electric

$10.83 /

+0.45 (+4.34%)

Management holds an…

Management holds an investor outlook conference call on March 4 at 8 am. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Centene to host conference call » 17:49
02/28/20
02/28
17:49
02/28/20
17:49
CNC

Centene

$52.90 /

+0.27 (+0.51%)

Chairman & CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Wolverine World Wide's Jeppesen sells 45,493 common shares » 17:49
02/28/20
02/28
17:49
02/28/20
17:49
WWW

Wolverine World Wide

$26.34 /

-0.55 (-2.05%)

In a regulatory filing,…

In a regulatory filing, Wolverine World Wide's president of Global Operations and Heritage Groups Michael Jeppesen disclosed the sale of 45,493 common shares of the company on February 27 at a price of $27.65 per share.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Westwater Resources files to sell 1M shares of common stock for holders  17:48
02/28/20
02/28
17:48
02/28/20
17:48
WWR

Westwater Resources

$1.77 /

+0.05 (+2.91%)

 
Periodicals
United Airlines to delay investor day set for March 5, Bloomberg says » 17:42
02/28/20
02/28
17:42
02/28/20
17:42
UAL

United Airlines

$61.42 /

-3.58 (-5.51%)

United Airlines has…

United Airlines has delayed its investor day, which was originally planned for March 5, to September, citing the coronavirus outbreak, Bloomberg reports.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Mondelez files automatic mixed securities shelf  17:40
02/28/20
02/28
17:40
02/28/20
17:40
MDLZ

Mondelez

$52.83 /

-1.61 (-2.96%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
FDA approves GSK's Advil Dual Action with Acetaminophen for OTC use » 17:39
02/28/20
02/28
17:39
02/28/20
17:39
GSK

GlaxoSmithKline

$40.51 /

-1.07 (-2.57%)

GlaxoSmithKline announced…

GlaxoSmithKline announced that the U.S. Food and Drug Administration has approved Advil Dual Action with Acetaminophen as an over-the-counter product for pain relief. The exclusive formula is now the first FDA-approved OTC combination of ibuprofen and acetaminophen in the United States and will be available over-the-counter nationwide in 2020. Franck Riot, Head of R&D, GSK Consumer Healthcare said: "For decades, many consumers have been using ibuprofen and acetaminophen to get the benefits of both active ingredients when safely treating their headaches, muscle aches, backaches, arthritis and other joint pain. Now Advil, the No. 1 selling OTC pain reliever, will offer US consumers the first-ever alternative option -- a single, fixed-dose combination pain reliever. As the world-leader in pain relief, Advil Dual Action and our recently FDA-approved Voltaren Arthritis Pain gel, demonstrates GSK's commitment to providing new safe, effective and convenient pain relief options for consumers."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Radian Group files automatic mixed securities shelf  17:37
02/28/20
02/28
17:37
02/28/20
17:37
RDN

Radian Group

$21.24 /

-0.495 (-2.28%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Lockheed Martin Comments awarded $141.66M Navy contract modification » 17:35
02/28/20
02/28
17:35
02/28/20
17:35
LMT

Lockheed Martin

$369.93 /

-9.89 (-2.60%)

Lockheed Martin was…

Lockheed Martin was awarded a $141.66M modification to a previously awarded fixed-price-incentive-firm-target contract. This modification provides for the stand-up of organic level repair capabilities for the combat aircraft F-35 communications, navigation and information system. Work is expected to be completed by June 2024. FY19 aircraft procurement funds in the amount of $70.83M, FY19 aircraft procurement funds in the amount of $35.41M and FY19 aircraft procurement funds in the amount of $35.41M will be obligated at time of award, none of which will expire at the end of the current fiscal year. The Naval Air Systems Command is the contracting activity.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Bell-Boeing awarded $165.28M Navy contract modification » 17:28
02/28/20
02/28
17:28
02/28/20
17:28
BA

Boeing

$275.23 /

-12.87 (-4.47%)

Bell-Boeing was awarded a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
General Motors to hire 1,200 new workers for Michigan plants, Bloomberg reports » 17:27
02/28/20
02/28
17:27
02/28/20
17:27
GM

General Motors

$30.48 /

-0.23 (-0.75%)

General Motors announced…

General Motors announced it will hire 1,200 new workers for its two plants in Lansing, Michigan, partly due to rising demand for the company's mid-sized sport utility vehicles, Bloomberg's David Welch reports. The company plans to add a third shift and 800 workers at its Lansing Delta Township plant, where it builds the Chevrolet Traverse and Buick Enclave SUVs. GM also will institute a second shift, including 400 new hires, at its Lansing Grand River factory. That facility makes the Chevy Camaro sports car and the all-new Cadillac CT4 and CT5 sedans. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Walmart names Iannone COO for U.S. e-commerce, Bloomberg says » 17:24
02/28/20
02/28
17:24
02/28/20
17:24
WMT

Walmart

$107.68 /

-2.67 (-2.42%)

Walmart has appointed…

Walmart has appointed Jamie Iannone as its COO for U.S. e-commerce, Bloomberg's Matthew Boyle reports. Iannone, who joined the retailer in 2014, was previously heading hte web, membership, and marketing operations of Sam's Club, Boyle says, citing a memo. At Sam's Club, who led several initiatives to improve customer service and increase online sales, the author notes. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Northrop Grumman awarded $262.28M Air Force contract modification » 17:24
02/28/20
02/28
17:24
02/28/20
17:24
NOC

Northrop Grumman

$328.32 /

-3.26 (-0.98%)

Northrop Grumman has been…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Vectrus awarded $121.78M Army contract modification » 17:20
02/28/20
02/28
17:20
02/28/20
17:20
VEC

Vectrus

$51.96 /

-0.34 (-0.65%)

Vectrus was awarded a…

Vectrus was awarded a $121.78M modification to a contract for continued support of critical operation, maintenance and defense of Army communications. Work will be performed in Kuwait, with an estimated completion date of August 28. FY20 operations and maintenance funds in the amount of $121.78M were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Chesapeake Granite announces NYSE determination to suspend trading of its units » 17:12
02/28/20
02/28
17:12
02/28/20
17:12
CHKR

Chesapeake Granite

$0.58 /

-0.0448 (-7.15%)

Chesapeake Granite…

Chesapeake Granite announced that it has received notification from the New York Stock Exchange of its determination to suspend trading of the trust's common units, effective immediately, and to initiate proceedings to delist the trust units. The determination to commence the delisting proceeding results from the trust's inability to satisfy the continued listing compliance standards set forth under Rule 802.01C of the NYSE listed company manual because the average closing price of the trust units fell below $1.00 over a 30 consecutive trading-day period, and the trust was unable to regain compliance with the applicable standards within a six-month cure period that concluded on February 28. As a result of the suspension, the trust expects that the trust units will begin trading on March 2 under the symbol (CHKR) on the OTC Pink Market, which is operated by OTC Markets Group.

Earnings
New Oriental Education cuts Q3 revenue view to $902.1M-$933.2M » 17:05
02/28/20
02/28
17:05
02/28/20
17:05
EDU

New Oriental Education

$128.27 /

-4.43 (-3.34%)

Q3 consensus $998.56M.…

Q3 consensus $998.56M. The company previously announced its outlook which estimated the total net revenues for the third quarter to be in the range of $983M-$1.006B, representing year-over-year growth in the range of 23%-26%. The weaker-than-expected revenues are mainly due to the impact of the outbreak of coronavirus in China, which was significantly offset by measures taken by the company to effectively move its offline classes to small size online live broadcasting classes through the self-developed OMO system during the quarter.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
TAL Education cuts Q4 revenue view to $850.1M-$871.9M, consensus $996.92M » 17:02
02/28/20
02/28
17:02
02/28/20
17:02
TAL

TAL Education

$54.44 /

-0.58 (-1.05%)

The company previously…

The company previously announced its outlook which estimated the total net revenues for the fourth quarter to be in the range of $959.1M-$980.9M. The weaker-than-expected revenues are mainly due to the impact of the outbreak of coronavirus in China and precautionary measures taken by the company with respect to its offline business, which was partially offset by the growth in student enrollments in online courses and related revenues for the quarter.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Acasti receves Nasdaq notification over minimum bid requirements » 17:01
02/28/20
02/28
17:01
02/28/20
17:01
ACST

Acasti Pharma

$0.43 /

-0.0126 (-2.88%)

Acasti Pharma announced…

Acasti Pharma announced that on February 28, 2020, it received written notification from the Nasdaq Listing Qualifications Department for failing to maintain a minimum bid price of U.S.$1.00 per share for the last 30 consecutive business days, as required by Nasdaq Listing Rule 5550a2 - bid price. The Nasdaq notification has no immediate effect on the listing of Acasti Pharma's shares. Under Nasdaq Listing Rule 5810c3A - compliance period, Acasti Pharma has 180 calendar days, or until August 26, 2020, to regain compliance. If at any time over this period the bid price of Acasti Pharma's shares closes at $1.00 per share or more for a minimum of ten consecutive business days, Nasdaq will provide written confirmation of compliance and the matter will be closed.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.